» Articles » PMID: 25933382

Caffeine Modulates Vesicle Release and Recovery at Cerebellar Parallel Fibre Terminals, Independently of Calcium and Cyclic AMP Signalling

Overview
Journal PLoS One
Date 2015 May 2
PMID 25933382
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebellar parallel fibres release glutamate at both the synaptic active zone and at extrasynaptic sites-a process known as ectopic release. These sites exhibit different short-term and long-term plasticity, the basis of which is incompletely understood but depends on the efficiency of vesicle release and recycling. To investigate whether release of calcium from internal stores contributes to these differences in plasticity, we tested the effects of the ryanodine receptor agonist caffeine on both synaptic and ectopic transmission.

Methods: Whole cell patch clamp recordings from Purkinje neurons and Bergmann glia were carried out in transverse cerebellar slices from juvenile (P16-20) Wistar rats.

Key Results: Caffeine caused complex changes in transmission at both synaptic and ectopic sites. The amplitude of postsynaptic currents in Purkinje neurons and extrasynaptic currents in Bergmann glia were increased 2-fold and 4-fold respectively, but paired pulse ratio was substantially reduced, reversing the short-term facilitation observed under control conditions. Caffeine treatment also caused synaptic sites to depress during 1 Hz stimulation, consistent with inhibition of the usual mechanisms for replenishing vesicles at the active zone. Unexpectedly, pharmacological intervention at known targets for caffeine--intracellular calcium release, and cAMP signalling--had no impact on these effects.

Conclusions: We conclude that caffeine increases release probability and inhibits vesicle recovery at parallel fibre synapses, independently of known pharmacological targets. This complex effect would lead to potentiation of transmission at fibres firing at low frequencies, but depression of transmission at high frequency connections.

Citing Articles

Neuroenhancement: State of the Art and Future Perspectives.

Marazziti D, Avella M, Ivaldi T, Palermo S, Massa L, Della Vecchia A Clin Neuropsychiatry. 2021; 18(3):137-169.

PMID: 34909030 PMC: 8629054. DOI: 10.36131/cnfioritieditore20210303.


The Impact of Coffee and Caffeine on Multiple Sclerosis Compared to Other Neurodegenerative Diseases.

Herden L, Weissert R Front Nutr. 2019; 5:133.

PMID: 30622948 PMC: 6308803. DOI: 10.3389/fnut.2018.00133.


The neuroprotective effects of caffeine in neurodegenerative diseases.

Kolahdouzan M, Hamadeh M CNS Neurosci Ther. 2017; 23(4):272-290.

PMID: 28317317 PMC: 6492672. DOI: 10.1111/cns.12684.

References
1.
Tazzeo T, Bates G, Roman H, Lauzon A, Khasnis M, Eto M . Caffeine relaxes smooth muscle through actin depolymerization. Am J Physiol Lung Cell Mol Physiol. 2012; 303(4):L334-42. PMC: 3774218. DOI: 10.1152/ajplung.00103.2012. View

2.
Peppiatt C, Collins T, MacKenzie L, Conway S, Holmes A, Bootman M . 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium. 2003; 34(1):97-108. DOI: 10.1016/s0143-4160(03)00026-5. View

3.
Montero M, Alonso M, Carnicero E, Cuchillo-Ibanez I, Albillos A, Garcia A . Chromaffin-cell stimulation triggers fast millimolar mitochondrial Ca2+ transients that modulate secretion. Nat Cell Biol. 2000; 2(2):57-61. DOI: 10.1038/35000001. View

4.
Bezprozvanny I, Bezprozvannaya S, Ehrlich B . Caffeine-induced inhibition of inositol(1,4,5)-trisphosphate-gated calcium channels from cerebellum. Mol Biol Cell. 1994; 5(1):97-103. PMC: 301012. DOI: 10.1091/mbc.5.1.97. View

5.
Boswell-Smith V, Spina D, Page C . Phosphodiesterase inhibitors. Br J Pharmacol. 2006; 147 Suppl 1:S252-7. PMC: 1760738. DOI: 10.1038/sj.bjp.0706495. View